Streetbeat News

Regulatory

CBOE

Cboe Digital announced it will launch margined Bitcoin and Ether futures on January 11, 2024, becoming the first U.S. regulated crypto native exchange and clearinghouse to offer spot and leveraged derivatives trading on a single platform. Supported by firms from both crypto and traditional finance sectors, the launch aims to provide capital efficiency and operational benefits. Cboe Digital will initially offer financially settled contracts, with plans for physically delivered products pending regulatory approval.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 3:12 pm

AAPL

AMZN

GOOG

META

MSFT

NVDA

QQQ

SPY

TSLA

Moody's has downgraded the U.S. credit outlook to negative, citing large federal deficits as a key driver. The deficits persist post-pandemic due to spending programs like the Inflation Reduction Act and Infrastructure Act. The downgrade occurred after market close on Friday with minimal immediate market reaction. Prudent investors are advised to diversify investments globally and across asset classes, and consider shorting strategies. Boeing (BA) is boosted by potential Chinese orders and Dubai Air Show prospects. Early trades show positive money flows in TSLA, NVDA, MSFT, and mixed in SPY and QQQ; negative in AAPL, AMZN, GOOG, META. Bitcoin is range-bound with speculation on ETF approval and BlackRock's Ethereum ETF filing. The Arora Report suggests a protection band strategy for investors.

Portfolio Pulse from The Arora Report

November 13, 2023 | 3:06 pm

QQQ

SPY

The conflict between Israel and Hamas continues to escalate, with Gaza's main hospital facing a severe fuel shortage and increasing casualties. The IDF has struck Hezbollah targets in Lebanon in response to attacks. Israeli Prime Minister Netanyahu is working to release hostages held by Hamas. The U.S. has expressed concerns over civilian casualties and is working with Qatar to provide humanitarian aid to Gaza. Additionally, the U.S. conducted airstrikes in Syria against Iranian targets. The Israeli shekel remained flat, while the Tel Aviv 125 index fell. U.S. ETFs SPY and QQQ saw gains in their last trading sessions.

Portfolio Pulse from Piero Cingari

November 13, 2023 | 2:55 pm

TENX

Tenax Therapeutics Inc (NASDAQ:TENX) stock surged 105% to $0.32 after receiving FDA clearance for the IND of TNX-103, an oral levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF). The clearance facilitates the launch of the Phase 3 LEVEL Study in Q4 2023, streamlining the process and potentially addressing a significant medical need as there are no FDA-approved treatments for PH-HFpEF. The company has already selected over two-thirds of the targeted research sites for the study.

Portfolio Pulse from Henry Khederian

November 13, 2023 | 2:47 pm

TSLA

Tesla Inc (NASDAQ:TSLA) is being discussed due to reports of India considering tax cuts on EV imports to attract Tesla and a potential meeting between CEO Elon Musk and Indian trade minister Piyush Goyal. Additionally, EG Group plans to buy Tesla charging units for its European network, and Tesla's FSD software version 12 is expected to be testable in two weeks. Tesla shares were down 1.23% at $212.19 at the time of publication.

Portfolio Pulse from Adam Eckert

November 13, 2023 | 2:46 pm

FXI

SPY

U.S. Treasury Secretary Janet Yellen met with China's Finance Minister and emphasized the importance of maintaining open communication channels between the two countries.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 2:41 pm

ZYXI

Zynex, Inc. (NASDAQ:ZYXI) has submitted a 510(k) application to the FDA for its new NMES device, the M-Wave, which is designed to replace the E-Wave. The M-Wave aims to provide a more effective and user-friendly treatment for neuromuscular conditions and can be used in both clinical and home settings. This submission is a key step in Zynex's strategy to innovate and deliver advanced medical devices to patients.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 2:19 pm

ASUR

Asure Software, Inc. (NASDAQ:ASUR), a licensed money transmitter, has announced the launch of its Treasury Compliance Services to help payroll providers with compliance demands related to money movement. The service addresses state money transmission laws, the Bank Secrecy Act, and NACHA Operating Rules. Asure's partnership with J.P. Morgan enhances its ability to offer a comprehensive solution. The service will be available in Q4 2023 and aims to simplify compliance for payroll providers, allowing them to focus on their core business.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 2:15 pm

GSK

GSK has received a positive CHMP opinion recommending momelotinib for myelofibrosis patients with anaemia, according to an SEC filing. If approved, momelotinib would be the first EU treatment specifically for myelofibrosis patients with moderate to severe anaemia. The decision on EU marketing authorization is expected by early 2024.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 2:13 pm

GCTK

Glucotrack, Inc. (NASDAQ:GCTK) has announced a strategic shift from non-invasive point-in-time glucose monitoring to continuous glucose monitoring (CGM) technology. The company's CEO, Paul V. Goode, PhD, provided a shareholder update letter highlighting the change due to new clinical guidelines and market trends favoring CGM over traditional blood glucose monitoring (BGM). The company has made progress in developing an implantable CGM with a two-year sensor life and is preparing for long-term preclinical studies. Glucotrack is also exploring acquisitions and strategic collaborations to expand its portfolio.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 2:12 pm